Baylor University Medical Center Proceedings April 2014, Volume 27, Number 2 | Page 120

RHEUMATOLOGY
421. Becker AM, Dao KH, Han BK, Kornu R, Lakhanpal S, Mobley AB,
Li QZ, Lian Y, Wu T, Reimold AM, Olsen NJ, Karp DR, Chowdhury
FZ, Farrar JD, Satterthwaite AB, Mohan C, Lipsky PE, Wakeland
EK, Davis LS. SLE peripheral blood B cell, T cell and myeloid cell
transcriptomes display unique profiles and each subset contributes to
the interferon signature. PLoS One 2013;8(6):e67003.
422. Bykerk VP, Cush J, Winthrop K, Calabrese L, Lortholary O, de Longueville
M, van Vollenhoven R, Mariette X. Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical
trials. Ann Rheum Dis 2013 Oct 3 [Epub ahead of print].
423. Cush JJ. Autoinflammatory syndromes. Dermatol Clin 2013;31(3):
471–480.
424. Cush JJ. Infection update. Drug Safety Quarterly 2013;4(2):1–3.
425. Cush JJ. TNF inhibitors and severe hepatic injury. Drug Safety Quarterly
2013;4(3):3.
426. Cush JJ, Dao KH, Orozco C. TNF inhibitors and heart failure. Drug
Safety Quarterly 2013;4(1):1–2.
427. Cush JJ, Weinblatt ME, Kavanaugh A, eds. Rheumatoid Arthritis, 4th
ed. New York: Professional Communications, 2013.
428. Furst DE, Mandell B, Calabrese LH, Cather JC, Clauw DJ, Deodhar
A, Kremer JM, Lewiecki EM, McMahon M, T Ritchlin C. Proceedings
of the 5th annual Perspectives in Rheumatic Diseases. Semin Arthritis
Rheum 2013;43(3):416–419.
429. Guiducci C, Gong M, Cepika AM, Xu Z, Tripodo C, Bennett L,
Crain C, Quartier P, Cush JJ, Pascual V, Coffman RL, Barrat FJ. RNA
recognition by human TLR8 can lead to autoimmune inflammation.
J Exp Med 2013;210(13):2903–2919.
430. Hsia EC, Cush JJ, Matteson EL, Beutler A, Doyle MK, Hsu B, Xu S,
Rahman MU. Comprehensive tuberculosis screening program in patients
with inflammatory arthritides treated with golimumab, a human antitumor necrosis factor antibody, in phase III clinical trials. Arthritis Care
Res (Hoboken) 2013;65(2):309–313.
431. Kavanaugh A, Fleischmann R, Bergman MJ, Ruderman E, Troum O, Wells
AF, Martin G, Calabrese LH, Gibofsky A, Strand V, Cush JJ. Proceedings
of the 2013 Rheumatology Winter Clinical Symposia. Semin Arthritis
Rheum 2013;42(6):667–673.
432. van der Heijde D, Tanaka Y, Fleischmann R, Keystone E, Kremer J, Zerbini
C, Cardiel MH, Cohen S, Nash P, Song YW, Tegzová D, Wyman BT,
Gruben D, Benda B, Wallenstein G, Krishnaswami S, Zwillich SH, Bradley
JD, Connell CA; ORAL Scan Investigators. Tofacitinib (CP-690,550) in
patients with rheumatoid arthritis receiving methotrexate: twelve-month
data from a twenty-four-month phase III randomized radiographic study.
Arthritis Rheum 2013;65(3):559–570.
433. Weinblatt ME, Kremer J, Cush J, Rigby W, Teng LL, Devenport J,
Singh N, Lepley D, Genovese MC. Tocilizumab as monotherapy or in
combination with nonbiologic disease-modifying antirheumatic drugs:
twenty-four-week results of an open-label, clinical practice study. Arthritis
Care Res (Hoboken) 2013;65(3):362–371.
SURGERY
Note: Most surgery articles are subclassified by specialty, even if general surgeons
were first authors or coauthors.
434. Crapko M, Fleshman J. Minimally invasive surgery for rectal cancer. Ann
Surg Oncol 2013 Sep 4 [Epub ahead of print].
435. de Montbrun SL, Roberts PL, Lowry AC, Ault GT, Burnstein MJ,
Cataldo PA, Dozois EJ, Dunn GD, Fleshman J, Isenberg GA, Mahmoud
NN, Reznick RK, Satterthwaite L, Schoetz D Jr, Trudel JL, Weiss EG,
Wexner SD, MacRae H. A novel approach to assessing technical competence of colorectal surgery residents: the development and evaluation
of the Colorectal Objective Structured Assessment of Technical Skill
(COSATS). Ann Surg 2013;258(6):1001–1006.
436. Dharmarajan S, Newberry EP, Montenegro G, Nalbantoglu I, Davis
VR, Clanahan MJ, Blanc V, Xie Y, Luo J, Fleshman JW Jr, Kennedy
S, Davidson NO. Liver fatty acid-binding protein (L-Fabp) modifies
intestinal fatty acid composition and adenoma formation in ApcMin/+
mice. Cancer Prev Res (Phila) 2013;6(10):1026–1037.

194

437. Fleshman J. Laparoscopic approaches in oncology. Surg Oncol Clin N
Am 2013;22(1):xi.
438. Fleshman JW. Multidisciplinary treatment of rectal cancer: the way of
the future. JAMA Surg 2013;148(8):778.
439. Grimm L Jr, Fleshman JW. Modern rectal cancer surgery—total mesorectal
excision—the standard of care. Sem Colo